Health Care Select Sector SPDR (XLV)

Add to Watchlists
Create an Alert
71.38 -1.28  -1.76% NYSE Arca Sep 29, 20:00 Delayed 2m USD
View Full Chart
XLV Price Chart

XLV Key Stats

Expense Ratio 0.14%
Share Class Assets Under Management 12.40B
30-Day Average Daily Volume Upgrade
Net Asset Value 71.36
Discount or Premium to NAV 0.03%
Turnover Ratio 3.25

XLV Performance

  Total Return Cat. Total Return (NAV) % Rank in Cat. (NAV) Cat. Total Return (Price) % Rank in Cat. (Price)
1M -2.15% 3.39% 90 3.32% 94
3M 0.87% 11.79% 79 11.47% 82
6M 5.84% 17.10% 76 16.84% 76
1Y 11.76% 7.98% 26 8.28% 19
3Y 47.15% 13.05% 35 13.10% 29
5Y 141.4% 20.28% 56 20.28% 53
As of Sept. 29, 2016

XLV Asset Allocation

Type % Net % Long % Short
Cash 0.03% 0.03% 0.00
Stock 99.97% 99.97% 0.00
Bond 0.00 0.00 0.00
Convertible 0.00 0.00 0.00
Preferred 0.00 0.00 0.00
Other 0.00 0.00 0.00
As of Sept. 28, 2016

XLV Region Exposure

Americas 100.0%
North America 100.0%
Latin America 0.00
Greater Europe 0.00
United Kingdom 0.00
Europe Developed 0.00
Europe Emerging 0.00
Africa/Middle East 0.00
Greater Asia 0.00
Japan 0.00
Australasia 0.00
Asia Developed 0.00
Asia Emerging 0.00
Market Classification
% Developed Markets 100.0%
% Emerging Markets 0.00
As of Sept. 27, 2016
Region breakdown data is calculated by using the long position holdings of the portfolio.

XLV Stock Sector Exposure

Basic Materials 0.00
Communication Services 0.00
Consumer Cyclical 0.00
Consumer Defensive 0.00
Energy 0.00
Financial Services 0.00
Healthcare 97.63%
Industrials 1.69%
Real Estate 0.00
Technology 0.67%
Utilities 0.00
As of Sept. 28, 2016

XLV Stock Market Capitalization

Giant 59.25%
Large 33.25%
Medium 7.50%
Small 0.00
Micro 0.00
As of Sept. 28, 2016

XLV Stock Style Exposure

Large Cap Value 9.49%
Large Cap Blend 27.27%
Large Cap Growth 55.74%
Mid Cap Value 0.60%
Mid Cap Blend 4.12%
Mid Cap Growth 2.78%
Small Cap Value 0.00
Small Cap Blend 0.00
Small Cap Growth 0.00
As of Sept. 28, 2016
View More Holdings

XLV Top 10 Holdings

Symbol Name % Weight Price % Chg
JNJ Johnson & Johnson 11.72% 117.27 -1.78%
PFE Pfizer Inc 7.40% 33.32 -1.97%
MRK Merck & Co Inc 6.28% 61.91 -2.20%
UNH UnitedHealth Group Inc 4.84% 138.32 -1.49%
AMGN Amgen Inc 4.56% 165.45 -2.51%
MDT Medtronic PLC 4.32% 85.40 -1.54%
ABBV AbbVie Inc 3.75% 62.82 -2.18%
GILD Gilead Sciences Inc 3.74% 77.86 -1.41%
AGN Allergan PLC 3.56% 230.80 -2.94%
BMY Bristol-Myers Squibb Company 3.32% 53.87 -2.21%
As of Sept. 28, 2016
Advertisement

One Page Reports

XLV Basic Info

Style
Equity Style Large Cap/Growth
Broad Asset Class Sector Equity
Broad Category Equity
Category Name Health
Prospectus Objective Specialty - Health
Fund Owner Firm Name SPDR State Street Global Advisors
Benchmark Index
S&P Health Care Select Sector TR USD
100.0%

XLV Manager Info

Name Tenure
John Tucker 16.59 yrs
Karl Schneider 1.58 yrs
Michael Feehily 5.59 yrs

XLV Net Fund Flows

1M -30.01M
3M 50.89M
6M -570.74M
YTD -1.057B
1Y -1.661B
3Y 2.134B
5Y 3.947B
10Y 5.289B
As of Aug. 31, 2016

XLV Risk Info

Beta 0.8313
Max Drawdown (All) 40.51%
Historical Sharpe (10Y) 0.7639
Historical Sortino (All) 0.6846
30-Day Rolling Volatility 12.96%
Daily Value at Risk (VaR) 1% (All) 3.08%
Monthly Value at Risk (VaR) 1% (All) 13.23%

XLV Fundamentals

Dividend Yield TTM (9-29-16) 1.55%
Weighted Average PE Ratio 22.24
Weighted Average Price to Sales Ratio 1.778
Weighted Average Price to Book Ratio 3.649
Weighted Median ROE 21.09%
Weighted Median ROA 8.16%
Forecasted Dividend Yield 1.69%
Forecasted PE Ratio 19.86
Forecasted Price to Sales Ratio 1.703
Forecasted Price to Book Ratio 3.125
Number of Holdings 60
As of Sept. 28, 2016

XLV Growth Estimates

Forecasted 5 Yr Earnings Growth 10.02%
Forecasted Book Value Growth 10.28%
Forecasted Cash Flow Growth 6.43%
Forecasted Earnings Growth 7.37%
Forecasted Revenue Growth 10.28%
As of Sept. 28, 2016

XLV Comparables

Edit

XLV Attributes

Key Dates
Inception Date 12/16/1998
Last Annual Report Date 9/30/2015
Last Prospectus Date 9/2/2016
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan Yes
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No

XLV Excel Add-In Codes

  • Name: =YCI("XLV","name")
  • Broad Asset Class: =YCI("XLV", "broad_asset_class")
  • Broad Category: =YCI("XLV", "broad_category_group")
  • Prospectus Objective: =YCI("XLV", "prospectus_objective")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.